FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Delaney David
 2. Date of Event Requiring Statement (Month/Day/Year)
08/09/2022		 3. Issuer Name and Ticker or Trading Symbol
Pasithea Therapeutics Corp. [KTTA]
(Last)
(First)
(Middle)
C/O CONCORD INVESTMENT PARTNERS LTD., 60 ST. CLAIR AVENUE EAST, SUITE 702		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) __X__ Other (specify below)
Member of 10% owner group
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

TORONTO, A6 M4T 1N5		 6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 226,521
I
See footnote (1)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Delaney David
C/O CONCORD INVESTMENT PARTNERS LTD.
60 ST. CLAIR AVENUE EAST, SUITE 702
TORONTO, A6 M4T 1N5		       Member of 10% owner group
Concord IP2 Ltd.
C/O CONCORD INVESTMENT PARTNERS LTD.
60 ST. CLAIR AVENUE EAST, SUITE 702
TORONTO, A6 M4T 1N5		       Member of 10% owner group
Elderhill Corp
C/O CONCORD INVESTMENT PARTNERS LTD.
60 ST. CLAIR AVENUE EAST, SUITE 702
TORONTO, A6 M4T IN5		       Member of 10% owner group

Signatures

/s/ David Delaney 08/16/2022
**Signature of Reporting Person Date
/s/ David Delaney, President of Concord IP2 Ltd. 08/16/2022
**Signature of Reporting Person Date
/s/ David Delaney, President of Elderhill Corporation 08/16/2022
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) 191,321 shares are held by Concord IP2, Ltd., of which David Delaney serves as sole director and President, and 35,200 shares are held by Elderhill Corporation, of which David Delaney serves as sole director and President.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.